Filter By Industry
Filter By Tag

Newsroom

ARS Therapeutics Press releases

1 - 10 of 15 Press Releases

Mar 25, 2017
Amyotrophic lateral sclerosis (ALS/Lou Gehrigs Disease) may be a severally under diagnosed disease.

Feb 19, 2017
A major Los Angeles hospital announced another clinical trial of l-serine for ALS/Lou Gehrigs disease patients. This will be the 3rd clinical trial of l-serine, a natural amino acid, for patients with Amyotrophic Lateral Sclerosis.

Feb 16, 2017
ARS Therapeutics™, a pioneer in the natural health supplements, announced a price reduction for it's ALS Complete L-serine supplement for ALS/Lou Gehrig's Disease patients worldwide.

Dec 31, 2016
ARS Therapeutics™, a pioneer in the natural health supplements, continues distribution on Amazon.com for its PD Complete L-serine supplement.

Dec 30, 2016
ARS Therapeutics™, a pioneer in the natural health supplements, continues distribution on Amazon.com for its ALS Complete L-serine supplement.

Dec 30, 2016
Parkinson's Disease (PD) affects one million people in the United States alone and seven million world-wide. Over 100,000 people died from PD in 2013 alone.

Oct 16, 2016
ARS Therapeutics™, a pioneer in the natural health supplements, continues distribution on Amazon.com for its ALS Complete L-serine supplement.

Oct 16, 2016
Parkinson's Disease (PD) affects one million people in the United States alone and seven million world-wide. Over 100,000 people died from PD in 2013 alone. There is no cure for Parkinson's Disease.

Oct 08, 2016
Parkinson's Disease (PD) affects one million people in the United States alone and seven million world-wide. Over 100,000 people died from PD in 2013 alone.

Oct 03, 2016
Parkinson's Disease (PD) affects one million people in the United States alone and seven million world-wide. Over 100,000 people died from PD in 2013 alone.


Page: 1 2 Next
ARS Therapeutics RSS Feed